Amlodipine Besylate and Benazepril Hydrochloride
- Product NDC
- 70934-944
- 11-digit product format
- 709340944
- Labeler code
- 70934
- Product ID
- 70934-944_f06c7406-c4fa-f600-e053-2995a90a9bc3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate and Benazepril Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA077183
- Marketing category
- ANDA
- Marketing start
- 2022-02-03
- Marketing end
- 2024-01-31
- Substance
- AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-944-90 | 70934094490 | 90 CAPSULE in 1 BOTTLE, PLASTIC (70934-944-90) | 90 capsule | 2022-02-03 | 0000-00-00 | No | No | Current |